focus -WSS

focus

author：comprehensive 2025-09-03 14:37:56 - browse：2615

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： STAT Virtual Event: The State of Biosimilars: What to Watch

WSS

Google and Epic fight stronger regulation of AI in health care

Divers poised to search for children washed away in Pennsylvania flash flood

7 more heat

Listen: Wegovy in the brain & pivotal Alzheimer's data

Custom gene therapy hints at new path for rare disease treatments

Tocagen's brain cancer gene therapy trial continues. Investors worry

leisure time

focus

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Listen: Wegovy in the brain & pivotal Alzheimer's data

After affirmative action ruling, medical educators look to 'holistic review'

Stanford president faces new allegations over 1999 paper

Sports medicine is finally prioritizing gender equality

How Medicaid coverage policies for immigrants impact new moms

Medical leaders decry Supreme Court decision on affirmative action

EF3 tornado rips through North Carolina amid extreme weather nationwide

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

entertainment

Judge rejects Trump's request to move Stormy Daniels hush

Startup Neumora takes a novel depression drug to Phase 3

A public scorecard can help hold safety

EF3 tornado rips through North Carolina amid extreme weather nationwide

Stanford president faces new allegations over 1999 paper

Tesla recalling nearly 16,000 of its 2021

knowledge

hotspot

hotspot

hotspot